HOME >> MEDICINE >> NEWS
Experts highlight cardiovascular and drug interaction risks in elderly patients

Boston, MA (September 30, 2002) Delegates attending the 7th International Conference on Geriatric Oncology reviewed data on the special treatment needs of elderly cancer patients. The data is relevant given the increased organ impairment (e.g. increased cardiovascular disease), and the increasing trend for multiple drug consumption ("poly-pharmacy") in the elderly cancer patient. Clinical trial experts say the potential risks to the elderly patient are underestimated due to restrictive clinical trial entry requirements.

Use of granisetron, an antiemetic drug with no cardiovascular restrictions and low potential for drug interactions is an appropriate choice for elderly cancer patients because granisetron is unlikely to create additional complications.

Antiemetics are used to treat chemotherapy and radiation therapy induced nausea and vomiting. Of the antiemetics, the 5HT3 receptor antagonists, like granisetron, are considered the gold standard in treatment and have a good tolerability and safety profile, particularly when compared to the other older antiemetics.

Differences, however, have been noted within the 5HT3 class in relation to the potential for cardiovascular toxicity and potential for adverse drug interactions.

Commenting on the cardiovascular risks from antiemetic therapy, Dr. Matti Aapro (Clinique de Genolier, Genolier, Switzerland) said, "The increased incidence of cardiovascular disease seen with increasing age necessitates careful consideration of the potential cardiotoxic properties of treatments."

"The increased risk from repeat cardiovascular insult in elderly patients with cardiovascular impairment is unknown, but the risk likely exists," said Dr. Aapro regarding clinical implications. "The cardiovascular side effect profile of antiemetics should be a key consideration in the elderly population and clinicians should be selecting the antiemetic with the lowest risk potential," he added.


'"/>

Contact: Whitney Hartmann
whitney.hartmann@shirehealthnewyork.com
212-725-7522
Shire Health New York
30-Sep-2002


Page: 1 2

Related medicine news :

1. Experts debate benefits, dangers of chlorine in C&EN point-counterpoint
2. Experts to discuss new advances in IBS therapy and its affect on IBS sufferers
3. Experts to discuss emerging technologies in GI diagnosis and treatment
4. Experts to discuss the affects of non-steroidal anti-inflammatory drugs (NSAIDs)
5. Experts present new research on the hot topics of aging at GSAs Annual Meeting
6. Experts welcome major reforms to the coroners service
7. Experts meet to challenge approaches of testing and developing cancer treatments
8. Experts gathering to discuss tapping into $40-$50 billion natural products market
9. Experts recommend increased funding, focus on resuscitation science
10. Experts announce global antimicrobial resistance initiative - World preview of the Global White Paper on bacterial resistance in respiratory tract infections - a call for concerted international action
11. Heart Experts Call For Action Against Missed Opportunities To Prevent Heart Disease In Women

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2019)... ... 14, 2019 , ... At this year’s Market America | ... cheered as it was announced that the company was now ranked the 36th largest ... the company has optimized its revolutionary “Shopping Annuity” program, making it possible for individuals ...
(Date:2/13/2019)... ... 2019 , ... Outside of nursing, most people believe bullies ... hospital units, ambulatory care centers, clinics, and even emergency departments. Their targets? Their ... of What to Do When Nurses Hurt Nurses, published by Sigma Theta Tau ...
(Date:2/13/2019)... ... February 13, 2019 , ... Today, leaders ... four days of programming occurring at SXSW 2019 in Austin, TX. Organizers ... and philanthropy to innovate, collaborate and activate initiatives aimed at increasing health ...
(Date:2/13/2019)... , ... February 13, 2019 , ... ... 2019, at the company’s annual member conference, Elevate 2019 at the Gaylord Rockies ... staff and members to explore potential partnerships driving improved quality of patient care, ...
(Date:2/13/2019)... ... 13, 2019 , ... That wintry landscape outside the window appears, oh, so ... driveways. Then, the snow can quickly become a pain in the “back, shoulder, neck, ... it,” says noted orthopaedic surgeon Kevin D. Plancher, MD, MPH , who equates ...
Breaking Medicine News(10 mins):
(Date:2/19/2019)... ... February 19, 2019 , ... Nativis, Inc., ( ... and other serious diseases, today announced the publication of a second study (NAT-105), ... that the Nativis Voyager device is safe for treatment of rGBM. , ...
(Date:2/19/2019)... ... February 19, 2019 , ... METAvivor ... Stage IV metastatic breast cancer (MBC), announces the opening of the 2019 metastatic ... “In honor of our 10-year anniversary, we are excited to announce we are ...
(Date:2/19/2019)... ... ... The American Academy of Thermology (AAT), which is the premiere organization ... infrared imaging, has announced details for its 2019 Annual Meeting & Scientific Session, which ... GA. , This is the first year that the AAT will be holding ...
Breaking Medicine Technology:
Cached News: